









Markets
/
Stocks
/
nasdaq-kynb
/

FibroGen Ord Shs

KYNB

9.220USD

-0.280-2.95%

Close 01/09, 16:00（ET）Quotes delayed by 15 min

--Market Cap

--P/E TTM



FibroGen Ord Shs

9.220

-0.280-2.95%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of FibroGen Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Total equity

Cash, cash equivalents and short-term investments

--117.97M

- Cash and cash equivalents

--117.97M

Receivables

--121.00K

-Accounts and notes receivable

--121.00K

-Other receivables

--0.00

Inventory

--3.86M

Prepaid expenses

--768.00K

Other current assets

--695.00K

Total current assets

--133.42M

Non-current assets

Other non-current assets

--556.00K

Total non-current assets

--3.59M

Total assets

--137.01M

Liabilities

Current liabilities

Accrued expenses

--25.78M

Deferred liabilities

--5.10M

Other current liabilities

--5.10M

Total current liabilities

--35.97M

Non-current liabilities

Long-term debt and lease liabilities

--19.47M

-Long-term debt

--19.47M

Deferred liabilities

--573.00K

Long-term accrued expenses

--63.41M

Other non-current liabilities

--671.00K

Total non-current liabilities

--83.56M

Total liabilities

--119.53M

Shareholders' equity

Common equity

--1.68B

Retained earnings

---1.69B

Capital reserves

--1.68B

Gains losses not affecting retained earnings

---2.21M

Non-controlling interests

--34.51M

Total equity

--17.48M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

